Meeting
2021 ASCO Annual Meeting
A comparative analysis of mortality between black and white stage III non–small cell lung cancer patients in the United States.
Authors
Elizabeth Blessing Elimimian
Cleveland Clinic Fl, Weston, FL
Elizabeth Blessing Elimimian , Rafael Arteta-Bulos , Hong Liang , Nadeem Bilani , Leah Elson , Diana Saravia , Evan W. Alley
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers
Track
Lung Cancer
Sub Track
Local-Regional Non–Small Cell Lung Cancer
Citation
J Clin Oncol 39, 2021 (suppl 15; abstr 8552)
DOI
10.1200/JCO.2021.39.15_suppl.8552
Abstract #
8552
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2020 ASCO Virtual Scientific Program
Actionable policy barriers for receiving standard of care treatment among unresected stage III non-small cell lung cancer (NSCLC) patients in the United States.
First Author: Zhiyuan Zheng
Poster
2020 ASCO Virtual Scientific Program
Concurrent and sequential chemoradiation therapy are associated with improved survival among unresected stage III non-small cell lung cancer patients in the United States.
First Author: Zhiyuan Zheng
Poster
2020 ASCO Virtual Scientific Program
Contemporary management and associated outcomes of 3,151 patients with stage III non-small cell lung cancer (NSCLC) in a real-world setting: Results of KINDLE, a multicountry observational study.
First Author: Abdul Rahman Jazieh
Poster
2019 ASCO Annual Meeting
First subsequent treatment after discontinuation of durvalumab in unresectable, stage III NSCLC patients from PACIFIC.
First Author: David Planchard